U.S. market Closed. Opens in 31 minutes

DRMAW | Dermata Therapeutics, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-31
RevenueN/AN/AN/AN/AN/A
Cost of RevenueN/AN/AN/A322.001.35K
Gross ProfitN/AN/AN/A-322.00-1.35K
Operating Expenses8.04M9.67M7.86M3.17M4.47M
Selling, General & Admin3.97M4.02M4.40M1.57M1.85M
Research & Development4.07M5.65M3.46M1.61M2.62M
Other Operating Expenses0N/AN/AN/AN/A
Operating Income-8.04M-9.67M-7.86M-3.17M-4.47M
Other Expenses / Income247.22K63.57K-45.61K-63.68K-250.75K
Before Tax Income-7.79M-9.61M-7.90M-3.24M-4.72M
Income Tax Expenses-8.04K-9.67K45.61K197.27K250.75K
Net Income-7.79M-9.61M-7.95M-3.43M-4.97M
Interest ExpensesN/A-63.57K45.61K197.27K250.75K
Basic Shares Outstanding194.00K690.67K520.54K520.54K520.54K
Diluted Shares Outstanding194.96K690.67K520.54K520.54K520.54K
EBITDA247.22K-9.67M-7.86M-3.17M-4.47M
EBITDA Margin0.00%0.00%0.00%0.00%0.00%
EBIT-7.80M-9.68M-7.86M-3.04M-4.47M
EBIT Margin0.00%0.00%0.00%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙